Table 3 Hazard ratio and 95% CI for age IPSS-R and the flow variables used in the models.

From: A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes

 

B***

HR (95% CI)

p

Age

0.024

1.024 (1.009–1.039)

0.002

IPSS-R

0.687

1.988 (1.583–2.497)

 < 0.0001

% total monocytes

0.039

1.040 (0.992–1.090)

0.106

% classical monocytes**

–1.940

0.144 (0.032–0.645)

0.011

% CD16+ monocytes*

0.345

1.425 (1.192–1.702)

 < 0.0001

% CD16+ monocytes**

1.944

6.98 (1.558–31.343)

0.011

Number of abnormal antigen expressions in monocytes

0.359

1.432 (1.142–1.795)

0.002

% CD34 + myeloid progenitors

0.156

1.169 (1.100–1.241)

 < 0.0001

Number of abnormal antigen expressions in myeloid progenitors

0.237

1.289 (1.075–1.546)

0.006

% H1

–7.068

0.001 (0.00–0.039)

 < 0.0001

  1. *Among all nucleated cells; **among all monocytes; ***B = cumulative regression coefficient.
Back to article page